BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/14/2025 5:49:33 AM | Browse: 57 | Download: 213
 |
Received |
|
2025-04-25 08:00 |
|
Peer-Review Started |
|
2025-04-25 08:00 |
|
First Decision by Editorial Office Director |
|
2025-05-17 03:37 |
|
Return for Revision |
|
2025-05-17 03:37 |
|
Revised |
|
2025-05-29 17:08 |
|
Publication Fee Transferred |
|
2025-05-31 18:35 |
|
Second Decision by Editor |
|
2025-07-01 02:40 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-07-01 07:38 |
|
Articles in Press |
|
2025-07-01 07:38 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-08-01 01:32 |
|
Publish the Manuscript Online |
|
2025-08-14 05:49 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
Contrast-enhanced ultrasound in evaluating the curative effect of interventional therapy in patients with liver cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Li-Ping Chen, Yan Dong, Jing-Guang He, Qing-Qing Yang and Zhi-Wen Hu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Science and Technology Program of Guangzhou |
No. 2024A03J1029 |
| Science and Technology Program of Chinese Medicine and Integrated Chinese and Western Medicine in Guangzhou |
No. 20252A010001 |
|
| Corresponding Author |
Zhi-Wen Hu, MD, Department of Medical Ultrasound, Guangzhou First People's Hospital, No.1 Panfu Road, Guangzhou 510180, Guangdong Province, China. charleyhu@163.com |
| Key Words |
Contrast-enhanced ultrasound; Liver cancer; Interventional therapy; Blood perfusion; Tumor microvessel density; Tumor markers; Alpha-fetoprotein; Perfusion recovery; Receiver operating characteristic curve |
| Core Tip |
This observational study highlights the value of contrast-enhanced ultrasonography (CEUS) in evaluating the therapeutic response of liver cancer patients to interventional therapy. CEUS enables real-time visualization of tumor perfusion patterns, microvessel density changes, and alterations in tumor markers. Among 124 patients, CEUS demonstrated high sensitivity (85.72%) and specificity (92.31%) in assessing treatment efficacy. Notably, tumor blood flow and tumor marker levels (alpha-fetoprotein, carcinoembryonic antigen, carbohydrate antigen 19-9) significantly decreased post-treatment. These findings support CEUS as a reliable, noninvasive tool for monitoring treatment outcomes and guiding clinical decision-making in liver cancer management. |
| Publish Date |
2025-08-14 05:49 |
| Citation |
Chen LP, Dong Y, He JG, Yang QQ, Hu ZW. Contrast-enhanced ultrasound in evaluating the curative effect of interventional therapy in patients with liver cancer. World J Gastrointest Oncol 2025; 17(8): 105818 |
| URL |
https://www.wjgnet.com/1948-5204/full/v17/i8/105818.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v17.i8.105818 |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
